Azido-PEG3-C3-OH de-PEG3-NH2 which may result in the

which may result in the inhibition of tumor angiogenesis

InChi: InChI=1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24

Pharmacokinetic investigation of AZ31 as a single agent and in combination with irinotecan revealed that plasma concentrations of AZ31 were highest 1-hour after administration followed by a stepwise decrease at 3

C2HF3O2/c1-33-30-34-19-18-25(35-30)21-37(27-12-10-24(32)11-13-27)43(40

Tetrahydroxyquinone can take part in a redox cycle with semiquinone radicals

Azido-PEG3-C3-OH de-PEG3-NH2 which may result in theAzido PEG3 C3 OH is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 1807512 36 2 Molecular Weight: 233. 26 Formula: C9H19N3O4 Chemical Name: 3 {2 [2 (2 azidoethoxy)ethoxy]ethoxy}propan 1 ol Smiles: [N ]=[N+]=NCCOCCOCCOCCCO InChiKey: UUSDGPCVMBHTRJ UHFFFAOYSA N InChi: InChI=1S C9H19N3O4 c10 12 11 2 5 15 7 9 16 8 6 14 4 1 3 13 h13H,1 9H2 Technical Data Appearance: Solid Power Purity: 98% (or refer